Buy Sun Pharmaceutical, says Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Sun Pharmaceutical is a more obvious buy; see how it has rallied 15 percent from the lows. Good quality stocks that have bluechips almost always give us protection from losses and that is Sun Pharmaceutical again. I would be a buyer because it is on the verge of another breakout on the upside.""Now this is momentum, we can’t say because it also relates to the Nifty but at least while the Nifty is going cheerful Sun Pharmaceutical is a buying opportunity, not only day trade, it is also something you want to carry over," he added. "We are buying Infosys at those higher elevated levels and I don’t mind that because the chances are that this is going to break out again. IT now gives us a sense that perhaps it is willing to go higher. Even Mindtree, where I was bearish earlier, seems to be suggesting that that bearishness was unfounded and the move is on the upside. I am just giving you a general idea that IT now seems to be coming out of the woods and at least the short-term view is becoming positive," he said.